Is this the end for Lynas Corporation Limited?

Rare earths miner ends negotiations with financier

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rare earths miner Lynas Corporation Limited (ASX: LYC) has ceased negotiations with its financier, in a sign it could be close to the end of its existence. Shares in the company have fallen 10% to 13.5 cents in mid-morning trading.

In an announcement today, Lynas says it has decided to cease negotiations with Japanese financial firm Nomura regarding a novation and amendment of Lynas' existing senior debt facility.

The company had lined up Nomura to arrange the purchase and amendment of its Sojitz/JOGMEC senior debt facility. Lynas had proposed to replace its existing semi-annual repayments with one repayment in June 2016, and was hoping to have the agreement in place before this month.

Under existing arrangements, Lynas is due to make a US$35 million repayment this month, but may not be able to afford it – without renegotiation or taking on more debt. The trouble is, potential financiers appear to be thin on the ground and the existing financiers at the end of their tether.

The Sojitz/JOGMEC facility was for an original amount of US$225 million – Lynas repaid US$10 million of that in January 2014. Lynas has also issued US$225 million in convertible notes to a US investment firm – Mt Kellett Capital Management. These notes are due to be repaid in full on July 25, 2016 – unless converted into shares in the company before then.

All up, Lynas had around A$457 million of debt on its books at the end of December 2013.

The company says it is still engaging with potential financiers and investors to restructure existing debt facilities or borrow more debt and other investment opportunities. But each of those alternatives requires the consent of its existing financier – which may not be forthcoming. The company is rapidly running out of options.

At the end of the day, Lynas is mainly suffering from the rapid fall in rare earth oxide prices, as we have noted here and here.

Unless prices rise significantly higher from here, it's questionable whether Lynas has a viable business model – despite the appeal of being one of only two rare-earth producers in the Western World. And there are no signs that prices will ever return to the highs set in 2011.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »